Citations

Citations to this article as recorded by  

• Therapeutic potential of S-nitroso-l-cysteine in improving cardiorenal function in eNOS-KO CKD mice
  Xiaofan Wu, Jiahe Zhao, Zhengqi Xu, Feng Jiang, Moran Wang, Jingwen Tao, Cuntai Zhang, Li Lin, Sheng Li
  Nitric Oxide.2026; 161: 9.     CrossRef
• Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study
  Zhongchen Li, Chunyu Yu, Heng Zhang, Runze Chen, Yan Zhao, Zhe Zheng
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial
  Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra, Eric Gumpricht
  Journal of Nutrition and Metabolism.2025;[Epub]     CrossRef
• The Impact of Glomerular Disease on Dyslipidemia in Pediatric Patients Treated with Dialysis
  Edward Zitnik, Elani Streja, Marciana Laster
  Nutrients.2025; 17(3): 459.     CrossRef
• Diabetes, Chronic Kidney Disease, and Vascular Ulcers: Prevention Strategies and Clinical Implications
  Stefano Mancin, Alfonso Zarrella, Fabio Petrelli, Simone Cosmai, Daniela Cattani, Diego Lopane, Sarah Scollo, Sara Morales Palomares, Marco Sguanci, Antonella Amendola, Giovanni Cangelosi, Beatrice Mazzoleni
  Diabetology.2025; 6(2): 10.     CrossRef
• Cardiovascular disease burden and associated risk factors in chronic kidney disease
  Roshan Bhandari, Srijan Pantha, Ghanashyam Pandey, Richa Paudyal
  Indian Journal of Medical Sciences.2025; 77: 120.     CrossRef
• Association of the Triglyceride-Glucose Index with Body Composition and Laboratory Parameters in Chronic Kidney Disease Stages 3–5
  Shan-Shan Xu, Yan-Meng Guan, Hong-Yun Xuan, Xiu-Fang Fan, Ping Lu, Li-Hai Hao
  Risk Management and Healthcare Policy.2025; Volume 18: 903.     CrossRef
• The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and pulmonary function: evidence from NHANES 2007–2012
  Miaoyan Liu, Chaofeng Gao, Jinggeng Li, Yibo Zhang, Rui Gao, Chaoting Yang, Jian Zhang
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005–2018
  Wei Tang, Zhengyi Long, Yang Xiao, Jingyun Du, Chenyuan Tang, JunXiang Chen, Can Hou
  Clinical Nutrition ESPEN.2025; 67: 453.     CrossRef
• From fat to filter: the effect of adipose tissue-derived signals on kidney function
  Nermin Ahmed, Carolina Dalmasso, Meghan B. Turner, Gertrude Arthur, Cole Cincinelli, Analia S. Loria
  Nature Reviews Nephrology.2025; 21(6): 417.     CrossRef
• CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE
  O. M. Bilovol, I. I. Kniazkova, V. O. Golovachova, N. V. Kuzminova, D. О. Kіrienko, O. M. Kіrienko, L. P. Abramova
  World of Medicine and Biology.2025; 21(91): 26.     CrossRef
• Analysis of the association between long-term exposure to low-dose ionizing radiation and dyslipidemia and its components in medical radiologists: The mediating role of inflammatory markers
  Changyong Wen, Xiaolian Liu, Yiqing Lian, Weizhen Guo, Lingyu Zhang, Yanting Chen, Xin Lan, Mingfang Li, Sufen Zhang, Weixu Huang, Jianming Zou, Huifeng Chen
  International Journal of Cardiology Cardiovascular Risk and Prevention.2025; 25: 200406.     CrossRef
• The protective effect of dietary sphingomyelin supplementation against impaired lipid metabolism in obese mice: a systematic review and meta-analysis of randomized controlled trials
  Xiao-Yan Qin, Jie Pan, Yi-Na Liu, Hui-Min Luo, Fang Yang
  Food, Nutrition and Health.2025;[Epub]     CrossRef
• Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications
  Francesco Perone, Marco Bernardi, Luigi Spadafora, Matteo Betti, Stefano Cacciatore, Francesco Saia, Federica Fogacci, Vikash Jaiswal, Elad Asher, Francesco Paneni, Salvatore De Rosa, Maciej Banach, Giuseppe Biondi Zoccai, Pierre Sabouret
  Journal of Cardiovascular Development and Disease.2025; 12(5): 171.     CrossRef
• Associations of cardiac biomarkers with chronic kidney disease and mortality in US individuals without prevalent cardiovascular disease
  Haitao Xie, Shi Wang, Li Qian, Peng Yu, Xiaohu Chen, Shuhua Tang, Le Shen
  Scientific Reports.2025;[Epub]     CrossRef
• Accurate Determination of Circulatory Lipids Using a Combination of HILIC-MRM and RPLC-PRM
  Kyeong-Seog Kim, Jae-Seung Lee, Seung Seok Han, Joo-Youn Cho
  Analytical Chemistry.2025; 97(18): 9713.     CrossRef
• Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring
  Aleksandra Kezić, Selena Gajić, Ana Račić Ostojić, Ivana Bekić, Ana Bontić, Jelena Pavlović, Marko Baralić, Ljiljana Popović
  Life.2025; 15(5): 798.     CrossRef
• Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
  Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
  Journal of Lipid and Atherosclerosis.2025; 14(2): 190.     CrossRef
• Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics
  Esra Cetin, Anne-Catherine Raby
  Cells.2025; 14(11): 770.     CrossRef
• Dynamic changes in metabolic syndrome components and chronic kidney disease risk: a population-based prospective cohort study
  Yue Huang, Rong Fu, Juwei Zhang, Jinsong Zhou, Siting Chen, Zheng Lin, Xiaoxu Xie, Zhijian Hu
  BMC Endocrine Disorders.2025;[Epub]     CrossRef
• Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study
  Jiaming Su, Jiyuan Hu, Hongfang Liu, Yan Guo, Yang Shi, Yicheng Zheng, Zhaoxi Dong, Jiayou Liu, Zheyu Xu, Xinhui Yu, Jie Mei, Jing Peng, Lin Wang, Qingqing Liu
  Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
• Suppressing ferroptosis via modulating FTH1 by silybin for treatment of renal fibrosis
  Jia-Qin Hu, Cang-Qiong Ning, Fang-Cao Pi, Xue-Ni Cai, Jian Zhou, Nan Wang, Li-Li Yu, Hua Zhou, Ying Xie
  Phytomedicine.2025; 145: 156937.     CrossRef
• Synergistic Effect of Banaba Leaf Extract and Policosanol (Raydel®) Ameliorate High Cholesterol and High Galactose-Diet Induced Adverse Events in Zebrafish
  Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Krismala Djayanti, Cheolmin Jeon
  Pharmaceuticals.2025; 18(6): 860.     CrossRef
• Association of Visceral Adiposity with Nephropathy in Patients with Diabetes Mellitus: Data from Chinese and US Cohorts
  Fan Zhang, Wenjian Li
  Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 1925.     CrossRef
• Cardiovascular Risk and Its Presentation in Chronic Kidney Disease
  Stefan J. Schunk, Paul Zimmermann
  Journal of Clinical Medicine.2025; 14(13): 4567.     CrossRef
• Prevalence and Correlates of Clinical Nephropathy in Patients With Type 2 Diabetes at Abia State Specialist Hospital and Diagnostic Center, Umuahia, Nigeria: A Cross-Sectional Study
  Izuchukwu E Okeji, Onyedikachi F Uzor, Christopher C Okafor, Silas U Okafor, Augustine I Airaodion, Obinna J Orji, Isaiah O Abali, Ikpembhosa J Esangbedo, Oladoyin Ogunbayo Jolaoye, Temitayo O Olaotan, Innocent Chima Zacs, Akudo B Umeh, Ugonna Emmanuel
  Cureus.2025;[Epub]     CrossRef
• Mitigating Lipotoxicity: A Potential Mechanism to Delay Chronic Kidney Disease Progression Using Current Pharmacological Therapies
  Suthiya Anumas, Reiko Inagi
  Nephrology.2025;[Epub]     CrossRef
• Lipid Accumulation and Insulin Resistance: Bridging Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease
  Xinyi Cao, Na Wang, Min Yang, Chun Zhang
  International Journal of Molecular Sciences.2025; 26(14): 6962.     CrossRef
• Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage
  Mehrdad Aghasizadeh, Ahmad Reza Bahrami, Maryam M. Matin
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2025; 1870(7): 159668.     CrossRef
• Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis
  Julie Ann Kemp, Marianna Mendonça, Paloma Chrispim, Marcia Ribeiro, Isadora Britto, Karen S. Coutinho-Wolino, Marcelo Ribeiro-Alves, Lia S. Nakao, Fernanda Kussi, Eduardo B. Coelho, Andresa A. Berretta, Denise Mafra, Ludmila Cardozo
  Toxins.2025; 17(8): 369.     CrossRef
• Co-Supplementation of Policosanol and Banaba Leaf Extract Exhibited a Cooperative Effect Against Hyperglycemia and Dyslipidemia in Zebrafish: Highlighting Vital Organ Protection Against High-Cholesterol and High-Galactose Diet
  Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Cheolmin Jeon
  International Journal of Molecular Sciences.2025; 26(16): 7669.     CrossRef
• Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
  Rahul Chikatimalla, Yash Vardhan Trivedi, Namita Ruhela, Shubhangi Singh, Amar Lal, Akhil Pawa, Baltej Singh, Rohit Jain
  Postgraduate Medicine.2025; 137(7): 588.     CrossRef
• Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs
  Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Alexandra-Ștefania Stroe-Ionescu, Mihail Virgil Boldeanu, Isabela Siloși, Lidia Boldeanu
  Life.2025; 15(8): 1287.     CrossRef
• Effect of NPB Capsules Consisting of Allium sativum, Hibiscus sabdariffa, Alisma plantago-aquatica, and Gynostemma pentaphyllum on Lipid Metabolism Disorders
  Hoang L. Hiep, Nguyen H. Ngan, Le H. Phu
  Tropical Journal of Natural Product Research.2025;[Epub]     CrossRef
• Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
  Eun Roh, Ji Hye Heo, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
  Diabetes & Metabolism Journal.2025; 49(5): 1106.     CrossRef
• Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential
  Shuangshuang Wei, Ying Fu, Yuqing Zeng, Wenwen Wu, Juan Cai, Zheng Dong
  Pharmacology & Therapeutics.2025; 275: 108930.     CrossRef
• Response to the Letter by Mehta and Sah Regarding Article, Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
  Mee Kyoung Kim
  Journal of Lipid and Atherosclerosis.2025; 14(3): 387.     CrossRef
• Patterns of lipid profile and genetic variations in South Asians
  Mahdi Rahmanian
  Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub]     CrossRef
• Isolated dyslipidemia triggers early kidney injury through fibrotic remodeling, subcellular lipid accumulation, and AMPK overexpression
  Mohamed El Fadel Ousmaal, Abderahim Gaceb, Anissa Benali, Jean Giaimis
  Ultrastructural Pathology.2025; 49(6): 537.     CrossRef
• Prevalence, predictors, and outcomes of coronary artery disease diagnosed by angiography in live-related kidney transplant candidates
  Muhammad Abdul Mabood Khalil, Nihal Mohammed Sadagah, Hinda Hassan Khideer Mahmood, Ibtisam Ali Alghamdi, Ghada Abdulrahman Buridi, Ahmed Abdelahad Basha, Alfatih Abdalla Altom, Aileen Jean Dela Cruz, Hitham Abdallah Ahmed Abdallah Ragab, Islam Nabil Elsa
  BMC Research Notes.2025;[Epub]     CrossRef
• Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation
  Maria Motrenikova, Krasimir Boyanov, Neli Bojinova, Anelia Bivolarska
  Antioxidants.2025; 14(10): 1259.     CrossRef
• Progression in adult patients with early-stage chronic kidney disease attending tertiary hospitals in Dodoma, Tanzania: prospective longitudinal study
  Denis D Katatwire, Alfred Meremo
  BMJ Open.2025; 15(11): e094121.     CrossRef
• Lipid lowering therapies in chronic kidney disease: A call to action
  Jaime Mazón-Ruiz, David Arroyo, Marina de Cos, María Riestra, Emilio Sánchez-Alvarez, Paula González Bores, Jose Luis Hernández, Pablo Corral
  Atherosclerosis.2025; 411: 120563.     CrossRef
• Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations
  Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
  The Korean Journal of Internal Medicine.2025; 40(6): 876.     CrossRef
• Direct medical cost analysis in the treatment of chronic kidney disease at Thong Nhat Dong Nai General Hospital in 2024
  Tran Ngoc Truong Giang, Tran Nguyen Mai Khanh, Pham Ngoc Bao Vy, Tran Tien An, Tieu Tu Man, Vo Ngoc Yen Nhi
  Tạp Chí Khoa học Trường Đại học Quốc tế Hồng Bàng.2025; : 11.     CrossRef
• Trends in Acute Myocardial Infarction Mortality Among Patients With Chronic Kidney Disease in the United States (1999–2024): A CDC WONDER Database Analysis
  Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Syeda Umbreen Munir, Sivaram Neppala, Yasar Sattar, Himaja Dutt Chigurupati, Jamal S. Rana, M. Chadi Alraies
  Cardiology in Review.2025;[Epub]     CrossRef
• Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches – systematic review
  Muhammad Bari Hassan, Sadia Siddique, Sandeep Kumar Maheshwari, Fnu Neelam, Fnu Neha, Bhawna Lohana, Kiran Lohana, Bismillah Athar Dar, Hina Kumari, Raja Pawan, Payal Bai, Sitara Jabeen, Ali Umair, Ali Karim, Zaghum Abbas, Ugal Kishore, Vikram Kumar, Abid
  Medicine.2025; 104(49): e46189.     CrossRef
• Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemic
  Mahtab Mashayekhi, Jonathan E. Zuckerman, Sahar H. Koubar, Junnan Wu, Jianbo Qing, Amir Abdipour, Edgar Lerma, Warren Peters, Sayna Norouzi
  Clinical and Experimental Nephrology.2025;[Epub]     CrossRef
• Association between hemoglobin-to-creatinine ratio and all-cause mortality in patients with coronary artery disease
  Bo Kang, Chun Zhang, Jie Li, Liang Chen
  The Egyptian Heart Journal.2025;[Epub]     CrossRef
• Cuban Sugarcane Wax Alcohol Supplementation Prevents Brain and Eye Damages of Zebrafish Exposed to High-Cholesterol and High-Galactose Diet for 30 Weeks: Protection of Myelin, Cornea, and Retina
  Kyung-Hyun Cho, Ashutosh Bahuguna, Cheolmin Jeon, Sang Hyuk Lee, Yunki Lee, Seung Hee Baek, Chae-Eun Yang, Ji-Eun Kim, Krismala Djayanti
  Antioxidants.2025; 14(12): 1453.     CrossRef
• Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients
  Liqin Cui, Min Yang
  Lipids in Health and Disease.2025;[Epub]     CrossRef
• Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials
  Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar
  Current Pharmaceutical Design.2024; 30(5): 362.     CrossRef
• Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report
  Junichiro Kato, Hideo Okonogi, Go Kanzaki, Haruki Katsumata, Yasuyuki Nakada, Makoto Sagasaki, Kazumasa Komine, Kenji Ito, Takao Saito, Akira Matsunaga, Koh Tokutou, Kazuho Honda, Nobuo Tsuboi, Takashi Yokoo
  BMC Nephrology.2024;[Epub]     CrossRef
• Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure
  Meng Yu, Hongyi Yang, Maobin Kuang, Jiajun Qiu, Changhui Yu, Guobo Xie, Guotai Sheng, Yang Zou
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Association between lipid accumulation product index and chronic kidney disease: A systematic review and meta-analysis
  Feixiang Wu, Chenmin Cui, Junping Wu, Yunqing Wang
  Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
• Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease
  Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, Amin Roshdy Soliman
  The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
• Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study
  Qingfei Yu, Qin Zhang
  International Journal of General Medicine.2024; Volume 17: 3919.     CrossRef
• Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology
  Radmila Žeravica, Branislava Ilinčić, Dragan Burić, Ana Jakovljević, Veljko Crnobrnja, Dalibor Ilić, Marija Vukmirović Papuga
  International Journal of Molecular Sciences.2024; 25(20): 11159.     CrossRef
• Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes
  Natalia Stepanova
  Biomedicines.2024; 12(10): 2377.     CrossRef
• Causal associations between kidney function and aortic valve stenosis: a bidirectional Mendelian randomization analysis
  Wanqian Pan, Le Zhou, Rui Han, Xiaojiao Du, Weixiang Chen, Tingbo Jiang
  Renal Failure.2024;[Epub]     CrossRef
• U-shaped association between dietary niacin intake and chronic kidney disease among US elderly: a nationwide cross-sectional study
  Zhouzhou Xie, Shansen Peng, Gejun Ou, Xiaoqi Zhou, Guihao Zhang, Huiming Jiang, Tianhui Zhang, Nanhui Chen
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Association between dried fruit intake and kidney function: research from univariate and multivariate Mendelian randomized studies
  Yuhang Gao, Xinghai Yue, Wanchao Zhao, Fang Yuan
  Frontiers in Nutrition.2024;[Epub]     CrossRef
• The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease
  Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso
  Biomolecules.2024; 14(11): 1393.     CrossRef
• Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population
  Yan-Fei Lai, Zhong-E Liang, Chun-Xiang Wu, Min Zhang, Zong-Hu Shi, Xiao-Yan Meng, Chun-Xiao Liu
  Lipids in Health and Disease.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Frequency of Diabetic Nephropathy among Patients of Type 2 Diabetes Mellitus
  Muhammad Irfan Jamil, Yasir Hussain, Muhammad Shahid Nawaz Khan, Anjum Shahzad, Azhar Iqbal, Adeel Ahmed, Iqra Naeem
  Pakistan Journal of Health Sciences.2025; : 18.     CrossRef
• Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD
  Hae-Ryong Yun, Young Su Joo, Hyung Woo Kim, Jung Tak Park, Nak-Hoon Son, Tae-Hyun Yoo, Shin-Wook Kang, Yaeni Kim, Soo Wan Kim, Yeong Hoon Kim, Kook-Hwan Oh, Seung Hyeok Han
  Journal of Nephrology.2025; 38(9): 2755.     CrossRef
• Intervention effects of optimised carbohydrate diet in patients with type 2 diabetes: study protocol for a randomised controlled crossover trial
  Yuwei LU, Ruiqi Zhang, Jingyi Yang, Dan Liu, Qian Wu, Xiaoxue Long, Di Cheng, Jingyi Guo, Qian Li, Ying Zhang, Piao Kang, Qinyi Wang, Xiaojing Gao, Rong Zeng, Mingliang Zhang, Qichen Fang, Weiping Jia, Yueqiong Ni, Huating Li
  BMJ Open.2025; 15(10): e106756.     CrossRef
• Interrelationship Between Dyslipidemia and Hyperuricemia in Patients with Uncontrolled Type 2 Diabetes: Clinical Implications and a Risk Identification Algorithm
  Lorena Paduraru, Cosmin Mihai Vesa, Mihaela Simona Popoviciu, Timea Claudia Ghitea, Dana Carmen Zaha
  Healthcare.2025; 13(20): 2605.     CrossRef
• Baseline predictors of in-hospital mortality among patients with chronic kidney disease admitted to the emergency department
  Arun Prabhahar, Niranjan A Vijaykumar, Harpreet Kaur, Navneet Sharma, Ashok K Pannu
  World Journal of Nephrology.2025;[Epub]     CrossRef
• Dietary management of patients with type 2 diabetes and chronic kidney disease: A comprehensive literature review
  Asmaa AlShammari, Ali AlSahow
  World Journal of Nephrology.2025;[Epub]     CrossRef
• Unveiling the utility of artificial intelligence for prediction, diagnosis, and progression of diabetic kidney disease: an evidence-based systematic review and meta-analysis
  Sagar Dholariya, Siddhartha Dutta, Amit Sonagra, Mehul Kaliya, Ragini Singh, Deepak Parchwani, Anita Motiani
  Current Medical Research and Opinion.2024; 40(12): 2025.     CrossRef
• Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Advanced Chronic Kidney Disease
  Cheol Ho Park, Hyunsun Lim, Youn Nam Kim, Jae Young Kim, Hyung Woo Kim, Tae Ik Chang, Seung Hyeok Han
  American Journal of Nephrology.2024; : 1.     CrossRef
• The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
  Dong-Hwa Lee
  Diabetes & Metabolism Journal.2023; 47(4): 484.     CrossRef
• Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis
  Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, Eyob Ketema Bogale, Amare Zewdie, Tadele Derbew Kassie, Tadele Fentabil Anagaw, Elyas Melaku Mazengia, Sintayehu Shiferaw Gelaw
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis
  Miao Zhu, Ruifang Guan, Guo Ma
  Frontiers in Endocrinology.2023;[Epub]     CrossRef